New research suggests that the shingles vaccine may offer protection against dementia, according to BBC Science Focus Magazine. The outlet reports that some people may be receiving this benefit without realizing it, as the vaccine is commonly given to older adults for its primary purpose of preventing shingles.
The findings stem from a natural experiment involving more than 280,000 adults in Wales, as reported by ScienceBlog.com. Over a seven-year period, researchers observed that individuals who received the shingles vaccination had 20% fewer new dementia diagnoses compared to those who did not get the shot. The study leveraged the fact that vaccine eligibility in Wales was based on age, creating a natural comparison group.
Further analysis by the same research team uncovered an additional layer to the results, according to ScienceBlog.com. The apparent protective effect appeared to extend to people who did not actually receive the vaccine, a finding the researchers described as strange. This suggests the benefit may not be limited to those who were directly vaccinated, though the exact mechanism remains unclear.
Additional coverage from Science Daily and Leader Publications also highlighted the link, with one report citing a 24% lower dementia risk associated with the shingles vaccine. The consistency across these reports points to a growing body of evidence that the vaccine's effects may reach beyond its intended use.
The research is observational, meaning it shows an association rather than proof of cause and effect. As scientists continue to investigate, the next step will be to determine whether the vaccine directly protects the brain or if other factors explain the connection.
